Objective: To compare 3% hypertonic saline and normal saline when given with L-
epinephrine nebulisation in the management of infants with moderate to severe …

Background: There is a dearth of therapeutic modalities for the management of bronchiolitis
in children. Objective: The objective of the study was to compare the improvement in clinical …

Background: Acute bronchiolitis is leading cause of hospitalization in infants below 2 years
of age. Bronchiolitis being a viral disease, there is no effective treatment. 3% nebulized …

Introduction: Bronchiolitis is commonly noticed condition in children, especially in infants
and characterised by inflammation of bronchioles. Inspite of this common occurrence the …

Abstract Background To Assess the efficacy of nebulised hypertonic saline (HS)(3%) among
children with mild to moderately severe bronchiolitis. Methods Infants aged 6 weeks to 24 …

Background: Acute bronchiolitis is an acute viral lower respiratory tract infection in early
childhood and is the leading cause of hospitalization in infants below 2 years of age. Being …

1. Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K. Nebulized 5%
or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr 2010; …

A meta‑analysis was performed to analyze the efficacy of 3% hypertonic saline (HS) in
bronchiolitis. Pubmed and MEDLINE databases were searched for relevant articles. A total …

Background: Bronchiolitis is a common lower respiratory tract ailment usually affects infants.
With few effective treatments, the health care cost of managing bronchiolitis is significant; …

Background Bronchiolitis is the most common lower respiratory infectious disease in infants
presenting with cough and/or wheeze and occurs most frequently in the winter months …